Weixian Deng

Weixian Deng is a Principal Scientist at Amgen, specializing in discovery proteomics with a focus on high-throughput screening and targeted protein degradation drug discovery. They possess extensive hands-on experience in proteomics technology, data analysis, and bioinformatics, and have demonstrated a commitment to developing and optimizing new technologies. Weixian earned a Ph.D. in Molecular Biology from the University of California, Los Angeles, where they trained in epigenetic processes and proteomics. Prior to their current role, they co-founded Xianjue Tech and held positions at Takeda and Amgen, as well as serving as a teaching assistant at UCLA.